Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
17.47B
Market cap17.47B
Price-Earnings ratio
21.49
Price-Earnings ratio21.49
Dividend yield
1.09%
Dividend yield1.09%
Average volume
2.14M
Average volume2.14M
High today
—
High today—
Low today
—
Low today—
Open price
$88.77
Open price$88.77
Volume
0.00
Volume0.00
52 Week high
$106.88
52 Week high$106.88
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $91.57. The company's market cap stands at 17.47B, with a P/E ratio of 21.49 and a dividend yield of 1.09%.

On 2026-10-06, Zimmer Biomet(ZBH) stock opened at $88.77, reached a high of —, and a low of —.

Zimmer Biomet(ZBH) shares are trading with a volume of 0, against a daily average of 2.14M.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $106.88 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $106.88 at its peak.

ZBH News

Simply Wall St 2h
Zimmer Biomet Holdings On Cost Reset Hopes Looks Undervalued But Is The Bounce Priced In

Zimmer Biomet Holdings (ZBH) has drawn fresh attention after a recent share move, with the price closing at US$91.57. Investors are weighing that level against...

Zimmer Biomet Holdings On Cost Reset Hopes Looks Undervalued But Is The Bounce Priced In
TipRanks 1d
Citi opens ‘upside 90-day catalyst watch’ on Zimmer Biomet

Citi analyst Joanne Wuensch opened an “upside 90-day catalyst watch” on Zimmer Biomet (ZBH) while keeping a Neutral rating on the shares with a $99 price target...

Analyst ratings

69%

of 29 ratings
Buy
27.6%
Hold
69%
Sell
3.4%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.